The peptidic urotensin‐II receptor ligand GSK248451 possesses less intrinsic activity than the low‐efficacy partial agonists SB‐710411 and urantide in native mammalian tissues and recombinant cell systems

David J. Behm, Stephen A. Douglas, Valeria Camarda et al.|British Journal of Pharmacology|2006

Cited by 36